A strategy for managing recombinant human Factor VIIa (NovoSeven®) off-label use in the academic hospital setting

被引:0
|
作者
Harris, SB [1 ]
Lögdberg, LE [1 ]
机构
[1] Emory Univ, Sch Med, Atlanta, GA 30322 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:159A / 159A
页数:1
相关论文
共 50 条
  • [21] Six Year, Single Institution, off-Label Use of Recombinant Factor VIIa.
    Patel, Mayur B.
    Bhattacharya, Syamal D.
    Williams, Judson B.
    Sweeney, Timothy E.
    Vaslef, Steven N.
    Hughes, G. Chad
    Kuo, Paul C.
    Lawson, Jeffery H.
    BLOOD, 2010, 116 (21) : 603 - 603
  • [22] Experience with the "Off label" use of recombinant factor VIIa in a university hospital.
    Escobar, MA
    Chong, K
    Hoots, KW
    BLOOD, 2004, 104 (11) : 90B - 91B
  • [23] Off-label use of recombinant factor VIIa in non-hemophilic patients.
    Culley, CM
    Spiro, RM
    Ragni, MV
    Triulzi, DJ
    Gross, PR
    Guttendorf, S
    Skledar, SJ
    PHARMACOTHERAPY, 2004, 24 (10): : 1437 - 1437
  • [25] Implementation of an off-label recombinant factor VIIa protocol for patients with critical bleeding at an academic medical center
    Jonathan Bain
    Daniel Lewis
    Andrew Bernard
    Kevin Hatton
    Hassan Reda
    Jeremy Flynn
    Journal of Thrombosis and Thrombolysis, 2014, 38 : 447 - 452
  • [26] Implementation of an off-label recombinant factor VIIa protocol for patients with critical bleeding at an academic medical center
    Bain, Jonathan
    Lewis, Daniel
    Bernard, Andrew
    Hatton, Kevin
    Reda, Hassan
    Flynn, Jeremy
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2014, 38 (04) : 447 - 452
  • [27] Off-label use of recombinant factor VIIa: why we need better drug monitoring
    Hebert, Paul C.
    Fergusson, Dean
    Stanbrook, Matthew B.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (01) : 26 - 27
  • [28] Off-Label Use of Recombinant Factor VIIa in United States Hospitals: 2000-2008
    Logan, Aaron C.
    Yank, Veronica
    Stafford, Randall S.
    BLOOD, 2009, 114 (22) : 33 - 34
  • [29] Life, limb or off-label recombinant VIIa use in the setting of limited blood assets: a case study
    Carr, Marcus E.
    Vickaryous, Brian
    BLOOD COAGULATION & FIBRINOLYSIS, 2013, 24 (04) : 436 - 438
  • [30] Off label use of recombinant factor viia in the hematology ward
    Rajic, N., V
    Rajic, N., V
    Popovic, S.
    Savic, A.
    Savic, I
    Urosevic, I
    Zeravica, B.
    Vlaisavljevic, N.
    Agic, D.
    Percic, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 856 - 856